Abivax S.A.
ABVXNext catalyst
Obefazimod
Moderately to Severely Active Crohn Disease
Get an email about ABVX's next catalysts
Track Abivax (ABVX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (earnings).See the timeline
2 upcoming, 0 past
Obefazimod Phase 2 Est. Readout (ENHANCE-CD)
Primary completion for Obefazimod trial (NCT06456593) in Moderately to Severely Active Crohn Disease
SourceABVX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-1.27 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
WebsiteABX464
Ulcerative Colitis
ABX203 therapeutic Hepatitis B vaccine treatment arm
Chronic Hepatitis B
ABX196
Carcinoma, Hepatocellular
Obefazimod
Moderately to Severely Active Crohn Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ABX464 | Phase 3 | Ulcerative Colitis | - | - |
ABX203 therapeutic Hepatitis B vaccine treatment arm | Phase 3 | Chronic Hepatitis B | - | - |
ABX196 | Phase 2 | Carcinoma, Hepatocellular | - | - |
Obefazimod | Phase 2 | Moderately to Severely Active Crohn Disease | - | - |
Frequently asked questions
What is in Abivax S.A.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Abivax S.A.'s (ABVX) pipeline across Phase 3, Phase 2. Its lead program is ABX203 therapeutic Hepatitis B vaccine treatment arm (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Abivax S.A.'s next FDA catalyst?→
Abivax S.A.'s (ABVX) next tracked catalyst is a Phase 2 readout expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ABVX biotech catalysts?→
Add ABVX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Abivax S.A.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.